10-Q Filing

Niagen Bioscience, Inc. CIK: 1386570 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-037809`
Period End Date	20230930
Filing Date	20231108
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	cdcx-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 60 Cash Flow Statement 75 Stockholders Equity 27

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Trade receivables, allowance	`AllowanceForDoubtfulAccountsReceivableCurrent`	$993.00K	USD	Point-in-time
Trade receivables, allowance	`AllowanceForDoubtfulAccountsReceivableCurrent`	$122.00K	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.77M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.26M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods presented	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.44M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventories	`InventoryNet`	$12.62M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventories	`InventoryNet`	$14.68M	USD	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	74.91M	shares	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	74.57M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$2.97M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$2.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.18M	USD	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	74.57M	shares	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	74.91M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$46.57M	USD	Point-in-time
Leasehold improvements and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.80M	USD	Point-in-time
Leasehold improvements and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.29M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$552.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$671.00K	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.00M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.52M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$497.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$454.00K	USD	Point-in-time
Total assets	`Assets`	$54.06M	USD	Point-in-time
Total assets	`Assets`	$53.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.68M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.20M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.19M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.34M	USD	Point-in-time
Current maturities of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$854.00K	USD	Point-in-time
Current maturities of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$680.00K	USD	Point-in-time
Current maturities of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$10.00K	USD	Point-in-time
Current maturities of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$16.00K	USD	Point-in-time
Customer deposits	`DeferredIncomeCurrent`	$189.00K	USD	Point-in-time
Customer deposits	`DeferredIncomeCurrent`	$157.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$19.44M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.96M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.81M	USD	Point-in-time
Operating lease obligations, less current maturities	`OperatingLeaseLiabilityNoncurrent`	$3.54M	USD	Point-in-time
Operating lease obligations, less current maturities	`OperatingLeaseLiabilityNoncurrent`	$2.91M	USD	Point-in-time
Finance lease obligations, less current maturities	`FinanceLeaseLiabilityNoncurrent`	$22.00K	USD	Point-in-time
Finance lease obligations, less current maturities	`FinanceLeaseLiabilityNoncurrent`	$14.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$26.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.39M	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; authorized 150,000 shares; 74,910 shares and 74,567 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$75.00K	USD	Point-in-time
Common stock, $0.001 par value; authorized 150,000 shares; 74,910 shares and 74,567 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$74.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$217.81M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$214.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-190.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-185.49M	USD	Point-in-time
Cumulative translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$-3.00K	USD	Point-in-time
Cumulative translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$-1.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$31.73M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$21.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$28.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$27.15M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$27.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.78M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$53.48M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$54.06M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Sales, net	`Revenues`	$17.06M	USD	1 Quarter
Sales, net	`Revenues`	$62.37M	USD	3 Qtrs
Sales, net	`Revenues`	$19.50M	USD	1 Quarter
Sales, net	`Revenues`	$51.05M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$20.27M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$24.53M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$6.86M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$7.53M	USD	1 Quarter
Gross profit	`GrossProfit`	$37.84M	USD	3 Qtrs
Gross profit	`GrossProfit`	$10.21M	USD	1 Quarter
Gross profit	`GrossProfit`	$11.97M	USD	1 Quarter
Gross profit	`GrossProfit`	$30.78M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$19.92M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$22.13M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$5.87M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$6.04M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.22M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.80M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.55M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.24M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.84M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$19.56M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.18M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$22.29M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$13.12M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$43.27M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$13.27M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$47.97M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.06M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.43M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-17.18M	USD	3 Qtrs
Other income, net - Employee Retention Tax Credit	`OtherIncomeNetEmployeeRetentionCreditCARESAct`	-	USD	1 Quarter
Other income, net - Employee Retention Tax Credit	`OtherIncomeNetEmployeeRetentionCreditCARESAct`	$2.08M	USD	3 Qtrs
Other income, net - Employee Retention Tax Credit	`OtherIncomeNetEmployeeRetentionCreditCARESAct`	$2.08M	USD	1 Quarter
Other income, net - Employee Retention Tax Credit	`OtherIncomeNetEmployeeRetentionCreditCARESAct`	-	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-5.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$188.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$379.00K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-23.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.05M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-985.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-959.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.12M	USD	3 Qtrs
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.22	USD	3 Qtrs
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareBasic`	$-0.07	USD	3 Qtrs
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.07	USD	3 Qtrs
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.22	USD	3 Qtrs
Diluted loss per common share attributable to ChromaDex Corporation (in dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.34M	shares	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	74.94M	shares	3 Qtrs
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.33M	shares	3 Qtrs
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	75.05M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	75.05M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.34M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.94M	shares	3 Qtrs
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.33M	shares	3 Qtrs

Cash Flow Statement 75 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$152.00K	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-5.05M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-985.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-959.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.12M	USD	3 Qtrs
Depreciation of leasehold improvements and equipment	`Depreciation`	$693.00K	USD	3 Qtrs
Depreciation of leasehold improvements and equipment	`Depreciation`	$648.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$119.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$143.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$638.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$520.00K	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$3.71M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$1.23M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$4.41M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$1.12M	USD	1 Quarter
(Gain) Loss on disposal of leasehold improvements and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.00K	USD	3 Qtrs
(Gain) Loss on disposal of leasehold improvements and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$5.00K	USD	3 Qtrs
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$200.00K	USD	1 Quarter
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$28.00K	USD	3 Qtrs
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$945.00K	USD	3 Qtrs
Non-cash financing costs	`OtherNoncashIncomeExpense`	$-60.00K	USD	3 Qtrs
Non-cash financing costs	`OtherNoncashIncomeExpense`	$-54.00K	USD	3 Qtrs
Trade receivables	`IncreaseDecreaseInOtherReceivables`	$-1.91M	USD	3 Qtrs
Trade receivables	`IncreaseDecreaseInOtherReceivables`	$-454.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$2.04M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-2.05M	USD	3 Qtrs
Implementation costs for cloud computing arrangement	`ImplementationCostsForCloudComputingArrangement`	$60.00K	USD	3 Qtrs
Implementation costs for cloud computing arrangement	`ImplementationCostsForCloudComputingArrangement`	$281.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.26M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-767.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.30M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-481.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.86M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$275.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-149.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-118.00K	USD	3 Qtrs
Customer deposits and other	`IncreaseDecreaseInDeferredRevenue`	$2.00K	USD	3 Qtrs
Customer deposits and other	`IncreaseDecreaseInDeferredRevenue`	$35.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-454.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-311.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.77M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.47M	USD	3 Qtrs
Purchases of leasehold improvements and equipment	`PurchasesOfLeaseholdImprovementsAndEquipment`	$127.00K	USD	3 Qtrs
Purchases of leasehold improvements and equipment	`PurchasesOfLeaseholdImprovementsAndEquipment`	$162.00K	USD	3 Qtrs
Proceeds from the sale of leasehold improvements and equipment, net	`ProceedsFromTheSaleOfLeaseholdImprovementsAndEquipmentNet`	-	USD	3 Qtrs
Proceeds from the sale of leasehold improvements and equipment, net	`ProceedsFromTheSaleOfLeaseholdImprovementsAndEquipmentNet`	$5.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-162.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-122.00K	USD	3 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$15.00K	USD	3 Qtrs
Principal payments on finance leases	`FinanceLeasePrincipalPayments`	$10.00K	USD	3 Qtrs
Principal payments on finance leases	`FinanceLeasePrincipalPayments`	$14.00K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.00K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-25.00K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.33M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-14.96M	USD	3 Qtrs
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.77M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.26M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.44M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.77M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.26M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $152 for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.44M	USD	Point-in-time
Cash payments for principal on operating lease liabilities	`OperatingLeasePayments`	$372.00K	USD	3 Qtrs
Cash payments for principal on operating lease liabilities	`OperatingLeasePayments`	$508.00K	USD	3 Qtrs
Adjustment to retained earnings, cumulative effect of initially adopting ASC 326	`StockholdersEquity`	$31.73M	USD	Point-in-time
Adjustment to retained earnings, cumulative effect of initially adopting ASC 326	`StockholdersEquity`	$21.02M	USD	Point-in-time
Adjustment to retained earnings, cumulative effect of initially adopting ASC 326	`StockholdersEquity`	$28.67M	USD	Point-in-time
Adjustment to retained earnings, cumulative effect of initially adopting ASC 326	`StockholdersEquity`	$27.15M	USD	Point-in-time
Adjustment to retained earnings, cumulative effect of initially adopting ASC 326	`StockholdersEquity`	$27.31M	USD	Point-in-time
Adjustment to retained earnings, cumulative effect of initially adopting ASC 326	`StockholdersEquity`	$20.78M	USD	Point-in-time

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$31.73M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$21.02M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$28.67M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$27.15M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$27.31M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$20.78M	USD	Point-in-time
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	3 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.41M	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.71M	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.23M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.12M	USD	1 Quarter
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	3 Qtrs
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$5.00K	USD	3 Qtrs
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.05M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-985.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-959.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.12M	USD	3 Qtrs
Ending balance	`StockholdersEquity`	$31.73M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$21.02M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$28.67M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$27.15M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$27.31M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$20.78M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.